Melodiol ponders options amid ‘challenging and volatile capital markets’ by Steve Jones June 19, 2024June 19, 2024 Health House International parent Melodiol Global Health is considering a sale and leaseback of its Mernova […]
Financial results: Bioxyne; Melodiol Global Health; Emyria; Zelira; Elixinol; Wellnex Life; Argent BioPharma by Steve Jones May 1, 2024May 1, 2024
Company news: Bioxyne/BLS; Rua Bioscience; Botanix; Melodiol Global Health; Zelira; Argent BioPharma by Martin Lane and Steve Jones April 16, 2024July 16, 2024
Health House parent becomes latest to report financial woes despite revenue growth by Steve Jones March 4, 2024March 6, 2024
Company news: Bioxyne/BLS; Wellnex Life; Elixinol Wellness; Althea; Health House; Rua Bioscience by Steve Jones and Martin Lane February 7, 2024November 25, 2024
Melodiol flags possible sale of core assets to raise capital by Steve Jones December 11, 2023December 13, 2023
Health House founder Paul Mavor ‘back in the pharmacy game’ by Martin Lane November 6, 2023April 30, 2024
Quarterly results: Elixinol; Emyria; Ecofibre; LGP; Bioxyne/BLS; Epsilon; Melodiol; MGC Pharma; AusCann; Neurotech; Wellnex Life; InhaleRx; Cannasouth by Steve Jones and Martin Lane November 1, 2023November 6, 2023
Health House International delivers profitable quarter for new owner Melodiol by Martin Lane October 16, 2023April 30, 2024
Financial results: Avecho; Wellnex; Zelira; Emyria; Botanix; MGC Pharma; AusCann; Epsilon; Melodiol; Bioxyne by Martin Lane and Steve Jones September 4, 2023April 30, 2024
